ArticleBlood cancer journal2018
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea.
Annalisa Pacilli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it